|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Generics in the United States |
|
|
|
|
€ 160,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Août 2005 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 55 pages | Décembre 2003 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,therapeutic classes,pharmaceuticals,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,india,china,mexico,japan,philippines,... |
| |
|
|
|
|
| 47 pages | Mai 2007 | Anglais
|
|
|
| Main
focus: |
generics,pharmaceutical,pharmaceuticals,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,germany,canada,france,united kingdom,italy,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
Pharmaceutical Packaging Market
80 pages | Avril 2002 |
This report will enable you to:Analyse the size of the UK market for pharmaceutical packaging between 1997 and 2006, by type: - cartons - containers - labels and leaflets - blister & strip p |
1 479,00 €
|
| |
| |
Chinese Markets for OTC Drugs
220 pages | Février 2002 |
China's demand for OTC drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic trend |
3 500,00 €
|
| |
| |
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val |
955,00 €
|
| |
| |
Healthcare In Southern Ireland
40 pages | Mai 2000 |
The Republic Of Ireland Presentation Includes:- The Structure Of The Health Service In The Republic Of Ireland- Capital Expenditure On Health Care In The Republic Of Ireland- Number Of Publicly Funded |
327,00 €
|
| |
| |
Generic Pharmaceutical Outlook 1998-2008
190 pages | Octobre 1998 |
Currently estimated to account for approximately 11% of Global pharmaceutical sales, this figure looks set to rise dramatically as branded drugs come off-patent within the next decade.
Imminent |
795,00 €
|
| |
| |
OTC Analgesics in Germany
15 pages | Juillet 2002 |
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year.
Over the review period, the m |
198,00 €
|
| |
| |
Healthcare: Germany
106 pages | Octobre 2000 |
Compare the changes in expenditure between the different healthcare sectors in Germany · Understand the main factors affecting demand for healthcare services in Germany · Examine the |
578,54 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave
160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
795,00 €
|
|
| |
| |
OTC Cough and Cold Remedies in Germany
15 pages | Juillet 2002 |
The German market for OTC cough and cold remedies reached a value of Euro 972 million (US$ 918 million) in 2001, up 0.4% on the previous year.
During the review period, the market grew by 9.4%, an |
198,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Generics in the United States |
|
|
Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies.
Scope
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and leading companies
* Includes a five-year forecast of the industry
* Supported by the key macroeconomic and demographic data affecting the market
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
|
|
TABLE OF CONTENTS
EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Competitive Landscape 12
CHAPTER 6 Leading Companies 13
6.1 IVAX Corporation 13
6.2 Merck & Co., Inc. 13
6.3 Mylan Laboratories Inc. 13
6.4 Novartis AG 14
6.5 Teva Pharmaceutical Industries 14
CHAPTER 7 Market Forecasts 15
7.1 Market Value Forecast 15
CHAPTER 8 Macroeconomic Indicators 16
CHAPTER 9 Further Reading 17
9.1 Sources 17
9.2 Related Datamonitor Research 17
LIST OF TABLES
Table 1: United States Generics Market Value: $ billion, 2000-2004 8
Table 2: United States Generics Market Segmentation I: % Share, by Value, 2004 9
Table 3: United States Generics Market Segmentation II: % Share, by Value, 2004 10
Table 4: United States Generics Market Value Forecast: $ billion, 2004-2009 14
Table 5: United States Size of Population (million) , 2000-2004 15
Table 6: United States GDP (1995=100), 2000-2004 15
Table 7: United States Inflation, 2000-2004 15
|
|
|
PPLSEN
|
|
|
|
|
